Применение медленной пролонгированной ультрафильтрации крови в лечении больных с декомпенсированной хронической сердечной недостаточностью
Диссертация
Впервые в России проведено исследование по применению МПУФ у пациентов с декомпенсацией ХСН с целью ликвидации признаков гипергидратации, в результате которого получены данные о том что методика МПУФ (низкая скорость удаления жидкости — не более 500 мл/час) позволяет нивелировать колебания центральной гемодинамики, существенно, не меняя состав электролитов, объёма циркулирующей крови и системное… Читать ещё >
Список литературы
- Беленков Ю.Н., Мареев В. Ю. Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. «Геотар-Медиа», Москва 2006
- Даниелян М.О. Прогноз и лечение хронической сердечной недостаточности (данные 20-и летнего наблюдения). Автореф. дис. канд. мед. наук. Москва. 2001
- Джеймс А. Шейман Кн. Патофизиология почки, Москва изд. Бином 2007- стр. 60−61.
- Заруба А.Ю., Куценко А. И., Босых Е. Г., Кухарчук В. В., Сочетанное применение гемосорбции и изолированной ультрафильтрации крови у больных с рефрактерной сердечной недостаточностью. Бюлл. ВКНЦ АМН СССР 1989- № 1: 72−78.
- Ю.Клепиков П. В., Цочтбояр Л., Ермоленко В. М., Милованов Ю. С. Применение изолированной ультрафильтрации при резистентном к действию диуретиков нефротическом отеке. Тер, архив, 1989, — N6, с. 9 4−9 5.
- П.Коновалов Г. А. Реанимационные аспекты последовательной ультрафильтрации и гемодиализа.- Автореф. дисс. канд, М., 1982.
- Коновалов Г. А., Денисов А. Ю., Михайлова Н. А., Савин А. В., Методы ультрафильтрации и гемофильтрации в клинике внутренних болезней, Тер. архив, 1989, N6, с. 89−90.
- Кулаков Т.П., Коновалов Г. А., Барсуков Ю. Ф. Изолированная ультрафильтрация при лечении хронической сердечной недостаточности. -Тер.архив, 1985, N4, с. 78−81
- Кулаков Г. П., Коновалов Г. А., Меликян Ф.М, Изолированная ультрафильтрация в лечении сердечной недостаточности при ишемической болезни сердца. Тер. архив, 1983, N9, с. 81−83
- Мухарлямов Н.М., Беленков Ю. Н. Ультразвуковая диагностика в кардиологии. М.Медицина. 1981: 156
- Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2005- 7: 52−78.
- Никифоров Ю.В. Продлённая гемодиафильтрация в комплексной терапии синдрома полиорганной недостаточности у оперированных больных. Экстракорпоральная непрерывная коррекция гомеостаза PRISMA технология, 2003:4−20.
- Расулов А.Р. Методические аспекты изолированной ультрафильтрации крови в условиях неспециализированного стационара, Анестез.- реанимат., 19 8 9,-N5, с. 7 5 -76.
- Самедов P.M., Гаджиев Г. Г., Гаджиев. Н. Г. Состояние центральной и периферической гемодинамики у больных с сердечной недостаточностью, леченных методом изолированной ультрафильтрации (по данным реографии).-Кардиология, 1991, N 11, с.42−44.
- Самедов Р. И., Гаджиев Г. Г., Ибрагимов Ф.Ш." Гаджиев Г. Г. Отдаленные результаты комплексной терапии сердечной недостаточности с применением изолированной ультрафильтрации. В кн.: Актуальные вопросы кардиологии. Баку,. 1988, с. 263−254.
- Самедов Р.И. Гельгафт Е, Б, Гаджиев Г.Г., Ибрагимов Ф. Ш., Гаджиев Н. Г. Изменение водных пространств у больных хронической сердечной недостаточностью под влиянием изолированной ультрафильтрации. -Кардиология, 19 9 О, N 5, с. 5 2 5 6.
- Самедов P.M., Гаджиев Н.Г, Гаджиев Г. Г. Опыт лечения больных с тяжелой сердечной недостаточностью с применением изолированной ультрафильтрации.- Кардиология, 1992, N9, с. 111 -112.
- Шиллер Н, Осипов М. А., Клиническая эхокардиография. М., Практика 2005, 344 с.
- Abraham W.T., Lowes BD., Ferguson D.A. et al. Systemic hemodynamic, neurogormonal and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with thermodynamically decompensated heart failure. J Card Fail 1998−4:37−44.
- Agostoni P, Marenzi G, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994- 96:191−9.
- Agostoni PG, Marenzi GC, Pepi M, Doria E, Salvioni A, Perego G, Giraldi F, Grazi S, guazzi MD. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993−21:424−431.
- Agostoni PG, Marenzi GC. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001- 96:183−189.
- Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003- 107: 226 -9.
- Asaba H., Bergstrom J., Furst P., Shaldon S. Treatment of diuretic-resistant fluid retention with ultrafiltration. Acta Med. Scand., 1978, v. 204- p. 145−149.
- Bardy GH, Lee KL, Mark DB, et al- Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005- 352:225−37.
- Bartone C, Saghir S, Menon SG, Brosmer J, Kereiakes DJ, Mazur W, Chung ES. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure. Congest Heart Fail. 2008 Nov-Dec- 14(6):298−301.
- Bassan R, Potsch A. Maisel A. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no-ST-segment elevation. Eur Heart J 2003- 26: 234−239.
- Bellomo R, Raman J, Ronco C. Intensive care unit management of the critically ill patient with fluid overload after open heart surgery. Cardiology 2001- 96:169−176.
- Bellomo R, Ronco C, Mehta R: Nomenclature for continuous renal replacement therapies. Am J Kidney Dis 1996- 28: S2-S7.
- Bellomo R, Ronco C: Acute renal failure in the intensive care unit: adequacy of dialysis and the case for continuous therapies. Nephrol Dial transplant 1996- 11: 424 428.
- Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, birt J, pressler ML. Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 1998- 7: 1680−174.
- Bergeron S., Tognarelli С, Pacitti A, Ultrafiltration in the treatment of refreactory congestive heart failure. International Symposium on Continuous Arteriovenous Hemofiltration. Milano: Wichting, 1986, p.247−253.
- Bergerone S., Pacitti A., Golzio P. Ultrafiltrazione nel trattamento dello scompenso cardiaco refrattario. Cardiologia, 1989, v.34, p.399−406.
- Bettencourt P., Azevedo A., Pimenta J. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2003,110: 2168−2174.
- Biagini A., Emdin M., Contini C., Piacenti M. Trattamento dello scompenso cardiaco mediante ultrafiltratione, In: Cardiologia 1986 Atti Dei XX Corso di Aggiornamento Cardiologico. Li b r e x: M i 1 a n o, 1986, p. 578−584
- Blake P, Paganini EP. Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration. Adv ren replace Ther 1996- 3: 166−173.
- Bosch J., Continous arteriovenous hemofiltration International Symposium on Continuous Arteriovenous Hemofiltration. Milano: Wichting, 1986, p. 9−35
- Bruneau B.G., Piazza L.A., de Bold A. J BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 1997- 273:2678−2686
- Burnett J.C., Granger J., Opgenorth T.J. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984- 247:863- 866.
- Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004- 147:331−8.
- Canaud B, Leblanc M, Leary-Moragues H, et all. Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 1998- 13:51−55.
- Cipolla C., Rimondini, Delia Bella P., Fabbiocchi F. Trattamento acuto dello scompenso cardiaco congesizio brefrattario a terapia medica mediante emofiltrazione Cardiologia, 1987. v .32, p.59 -72.
- Cipolla C., Grazi S., Rimondini A., Susini M. Changes In circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am. J. Card., 1990, v 86., p.987−994.
- Clark WR, Hamburger RJ, Lysaght MJ: Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int 1999- 56:2005−1015.
- Cleland JG, Daubert JC, Erdmann E, et al- Cardiac Resynchronization Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005- 352:1539−49.
- Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003- 24(5):442−463.
- Cody R.J., Laragh J.H. Use of captopril to estimate rennin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure. Am Heart J 1982- 104:11 841 189
- Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991- 325:303−10.
- Cohn JN, Tognoni G- Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001- 345:1667−75.
- Costanso MR, Saltsberg MT, Sullivan J, et all. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. JACC 2005- 46 (11): 2043−2051.
- Costanso MR, Guglin ME, Saltsberg MT, et all. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. JACC 2007- 49 (6): 675−683
- Costanzo MR Ultrafiltration in the management of heart failure. Curr Opin Crit Care. 2008 Oct- 14(5):524−30.
- Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997- 62: 187−93.
- Cowie M., Struthers., Wood D. et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997- 350: 13 491 353.
- Dahle TG, Blake D, Ali SS, Olinger CC, Bunte MC, Boyle AJ. Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters. J Card Fail. 2006 Jun- 12(5):349−52.
- Davis M., Espiner E., Richards G. et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994- 343: 440−444.
- Dhar S., Jeevan R., Lenyo L. Diuresis after hemodiaiysis associated with ultrafiltration on congestive cardiac failure. J. Indiana State Med, Assoc 1983, v. 7 6, p. 526−527.
- Di Leo M., Pacitti A, Bergerone S., Pozzi R. Ultrafiltration in the treatment refractory congestive heart failure. Cardiology, 1988, v.2, p, 139−150
- Domanski M, Norman J, Pitt B, et al. Studies of Left Ventricular Dysfunction. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003- 42:705−8.
- Dormans TP, Huige RM, Gerlag PG. Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose fiirosemide. Heart 1996- 75:349−351.
- Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diuretic efficacy of high dose fiirosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996- 28:376−82.
- Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001- 345:574−81.
- Dussarat G., Dalger J., Chateau J., Saissy J., Talard P. Traitement de lisuffisance cardiaque refractaire par ultrafiltration. Am. Cardiol. Ang., 1989, v. 33, p, 231−235.
- Dussarat G., Saissy J., Dalger J. Hemofiltration au long cours. Alternative au traitement de linsuifisance cardiaque congestive refractaire. Presse Med., 1987 v.35, p. 1762−1765.
- Elahi MM, Lim MY, Joseph RN, et al. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004 Nov- 26(5):1027−31.
- Ellison DII. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001- 96: 132−143
- Emerman CL, Marco TD, Costanzo MR, et al. Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry abstract. J Card Fail 2004- 10: S116.
- Faris R, Flather M, Purcell H, et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002- 82:149−58.
- Fauchald P., Forlang K., Amlie J. An evaluation of ultrafiltration treatment: of therapy resistant cardiac edema. Acta Med. Scand., 1986, v. 219. p. 47−52.
- Fauchald P., Noddeland H., Woseth J., An evaluation of ultrafiltration treatment: of therapy resistant edems in nephrotic Sinrome .-Acta Med. Scand., 1985, v. 247. p. 127−131.
- Floras J.S. Simpathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation 1990- 81: 1860−1873.
- Francis G. Approach to the patient with severe heart failure. In: Rose E, Stevenson L, eds. Management of End-Stage Heart Disease. Philadelphia: liprincott-Raven, 1998: 39−52.
- Friedman MM. older adults symptoms and their duration before hospitalization for heart failure. Heart Lung 1997- 26: 169−176.
- Gerhardt R. Effect of isolated ultrafiltration on colloid osmotic pressure and survival in cardiogenic shock. Abstr. Submitted to American Federation for Clinical Research, 1980, Jenuary, p. 10
- Gerhardt R., Abdulla a., Mach S., Hudson J., Isolated ultrafiltration in the therapy of volume overload accompanying oliguric vascular shock states, — Am. Heart J., 1979, v. 98, p. 567−572.
- Gerhardt R., Abdulla a., Mach S., Hudson J., Isolated ultrafiltration in the therapy of fluid overload in cardiogenic shock. —Arch. Int. Med., 1979, v. 139, p. 358−364.
- Ghali JK, Vaitkevicius P. Fluid removal: are we any wiser? J Card Fail 2008- 14:6−8.
- Glogar D., Stummvoll H., Wittels P. Hemofiltration: an alternative approach in treatment of severe congestive heart failure. Circulation. 1985, v. 72, p. 202−207.
- Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an Al adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002- 105:1348−53.
- Groenning BA., Nilsson JC, Sondergaard L. et al Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002- 143: 23−29.
- Guidelines for the Diagnosis and Management of Chronic Heart Failure: full text (update 2005). The Task Forse for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J 2005- 26: 1115−1140.
- Hampl H. Hemodynamic stadies during hemodialysis, sequential ultrafiltration and hemofiltration.- Dialys. Transplant., 1978, v.7, p. 83−91
- Hampl H., Paeprer H., Unger V. Hemodynamic changes during hemodialysis, sequential ultrafiltration and hemofiltration.- Kidney Int., 1980, v. 18, p. 88−91
- Harisaprasad M., Reddy K., Paul P., Ascitic ultrafiltration. Treatment for intractable congestive cardiomyopathy- NY State J. Med., 198 2, v.82,p.28−2 9.
- Hartmann F., Packer M, Coats A. et al. NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 2004- 6:343−350.
- Hays R., Levine S., Pathophysiology of water metabolism. In: Brenner В., Rector J. (eds.) The Kidney Phyladelphia, W.B. Saunders, 1991, p.777−840
- He X-R, Greenberg S, Briggs J, Schnermann J. Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated secretion. Hypertension 1995- 26:137−42.
- Henderson LW. Peritoneal ultrafiltration dialysis: enhanced urea transfer using hypertonic peritoneal dialysis fluid. J Clin Invest 1966- 45: 950−955.
- Holmes S.J., Espiner E.A., Richards A.M. et al Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993- 76−91−96.
- Hootkins R., Bourgeois B. The effect of ultrafiltration dialysance. Methematical theory and experimental verification. ASAY0 Trans., 1991, v.37, p. 375−377.
- Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino- terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 1997- 47: 287−96.
- Hunt PJ, Yandle TG, Nicholls MG, et al. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995- 214: 1175−83.
- Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005- 112:1825−52.
- Ing Т., Chen W., D a u g ir d a s J. Isolated ultrafiltration a n d new techniques of ultpafi 11 ration during dialysis, Kidney Tnt., 1980 v. 18, p.77−82
- Iorio L, Simonelli R, Nacca RG, DeSanto LS. Daily hemofiltration in severe heart failure. Kidney Int Suppl 1997- 59: S62−65.
- Jaarsma T, Halfens R, Huijer Abu-Saad H, Dracup K, Corgels T, van Ree J, Stappers J. Effects of education and support on self-care and resourse utilization in patients with heart failure. Eur Heart J 1999- 20: 673−682.
- Jain P, Massie BM, Gattis WA, et al. Current medical treatment for exacerbation of chronic heart failure resulting in hospitalization. Am Heart J 2003- 145: S3-S17.
- Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005- 95:948−54.
- Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003- 9:227−31.
- Jaski BE, Romeo A, Ortiz B, Hoagland PM, Stone M, Glaser D, Thomas L, Walsh C, Smith SC Jr. Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration. J Card Fail. 2008 Aug- 14(6):515−20. Epub 2008 May 27.
- Jernberg Т., James S., Lindahl В et al Nt-proBNP in unstable coronary artery disease periences from the FAST, CUSTO IV and FRISC II trials. Eur J
- Heart Fail 2004- 6: 319−325.
- Kazanegra R, Cheng V., Garcia A. et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated hearts failure: a pilot study. J Card Fail 2001- 7: 21−29.
- Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechahisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993- 132: 1961−1670.
- Kohno M., Horio Т., Yokokawa K. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992- 92: 29−34.
- Kol Abbate A., Piacenti M., Panichi V., Biagini A. Ultrafiltration: a rational treatment for heart failure. Cardiology, 1989, v. 76, p. 384−390.
- Koller W., Luger Т., Putensen C., Putz G. Blutreingende verfaren in der Intensiv Medizin. klin. Anasthesiol. Intensivther., 1991. v.39, p.404−406.
- Konig P., Geissler D., Bechleitner P., Spilberger M. Improved management of congestive heart failure
- Kramer BK, Schweda F, Riegger GAJ. Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999- 106: 90−96,
- Kramer P., Wigger W., Rieger J. Arteriovenous heamofiltration: a new and simple method for treatment of overhydrated patients resistand to diuretics. Klin. Wochenschr, 1977, v. 55, p. 1121−1122.
- Latini R., Masson S., Anand I. et al. Effect of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2002- 106:2454−2458.
- Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosh JP: Continuous arterio-venous hemofiltration in the critically ill patient. Ann Intern Med 1983- 99: 455−460.
- Levey A.S., Coresh J., Balk E. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137−147.
- Levin E.R., Gardner D.G., Samson W.K. Mechanisms of disease: natriuretic peptides. N Engl Med 1998- 339:321−328.
- Levy D, Kenchaiah S, Larson MG, et al- Framingham Heart Study. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002- 347: 1397−402.
- Ljungman S, Laragh JH, Cody RJ: Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 1990- 9 (suppl 4): 10−2
- Lopes-Uriarte A. Sequential ultrafiltration on periodic hemodialysis- Arch Invest.Med., 1983, v. 183, p 275−236
- Luchner A., Burnett J., Jougasaki M. et al. Augmentation of the cardiac natriuretic peptides by beta-reception antagonism: evidence from a population-based study. Am Coll Cardiol 1998- 32: 1839−1844.
- Magga J., Marttila M., Mantymaa P. et al. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infuseed conscious rats. Endocrinology 1999- 134: 2505−2515.
- Maisel A., Krishnaswamy P., Koon J. Utility of В-natriuretic peptide as a rarid, point of care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001- 141: 367−374.
- Maisel A., Krishnaswamy P., Nowak R. Rapid measurement of B-natriuretic peptide in emergency diagnosis of heart failure. N Engl J Med 2002- 347: 161−167.
- Mangilligan D., Oyama C. Ultrafiltration during cardiopulmonary bypass: Laboratory evaluation and initial clinical experience. -Ann. Thorac. Srug., 1984, v. 37, p.33−38
- Mangilligan D. Indications for ultrafiltration in the cardiac surgical patient. J. Thorac. Cardiovase Surg., 1985, v. 189, p. 183−189.
- Mansell M. Ultrafiltration and hemofiltration for refractory congestive cardiac failure (letter). Lancet. 1989. v.l. p. 1930
- Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001- 38:963−8.
- McDonagh Т., Robb S., Murdoch D. et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998- 351: 9−13.
- Mehrotra R, Khanna R. Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future. Cardiology 2001- 96: 196−201.
- Mehta RL: fluid management in CRRT. Contrib Nephrol 2001- 132: 335−348.
- MiletoG, Pitrone F, Princi P, et all. Treatment of refractory heart failure with different dialysis techniques. Recenti Prog Med 1996- 87:62−70.
- Misler S., Nidus B. Long- term ultrafiltration as a treatment of refractory congestive refractaire. —Presse Med., 1 987. v. 35. p. 1761 1766.
- Morales M., Piacenti M., Morcarelli E. Superiority of Doppler technique to detect beneficial effects of extracorporeal ultrafiltration in patients with severe congestive cardiomiopathy.- heart Vessels, 1993, (suppl. 3), p.46.
- Morgan S., Mansel M., Thompson F. Fluid removal by hemofiltration in diuretic resistant cardiac failure. Br. Heart J., 1985, v. 54, p.218−219
- Morita E., Yasue H., Yoshimura M. et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993- 88: 82−91.
- National Kidney Foundation: K/DOQI clinical practice guidelinesfor chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39: Sl-266.
- Neidecker J., Ninet J., Lamborez D., Estanove S. Peroperative ultrafiltration in с о m p le t e repair о f ventricular s e pt a 1 defect in infants. Presse Med., 1989, v. 18, p. 182−186.
- Neuberg GW, Miller AB, O’Connor CM, et al- PRAISE Investigators. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 2002- 144:31−8.
- Nishizaki S., Masaoka Y., Takioka M., Mikouchi H. Success of ultrafiltration method in a case of refractory heart failure. Shinso, 1982, v 14, p. 506 508.
- Odar- Cederlof J., Kyellstrand C., Theodorsson E. A hemodialysis patient with heart failure and severe overhydration but near-normal plasma levels of ANP. -Nephron, 1991, v.57, p. 495−496.
- Pacitti A., Tornarelli G., Bergerone S., Pozzi R. Impiego dell ultrafiltrazione nel trattamento dello scompenso cardiaco refrattario. Atti. del XVI Corso Nazionale di Aggiornamento. Rimaniazione e Terpia Intensiva. Millano: Piccin, 1986, p.111−118.
- Packer M, Bristow MR, Cohn JN, et al- U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996- 334:1349−55.
- Paganini E. Slow continous ultrafiltration (SCUF) — Proceedings of the Third International Simposium on Acute Continous Renal replacement Therapy. Fort Lauderdale: Florida. 1987, p. 37−57.
- Pederson J Rodriques S., Lisch F. Colloid osmotic pressure and refilling rate during isolated ultrafiltration and regular dialisis Kidney Int., 1992, v.21, p. 175 179.
- Pepi M, Marenzi GC, Agostoni PG, et al. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 1993- 70:135−40.
- Pitt B, Zannad F, Remme WJ, et al- Randomized Aldactone Evaluation Study (RALES) Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999- 341:709−17.
- Ramirez A, Abelmann WH. Cardiac decompensation. N Engl J Med 1974−290: 499−501.
- Rector Th., Cohn J. Assessment of patient outcome with the Minnesota Living with Fleart Failure questionnaire: Reliability and validity during a randomized, double-mind, placebo-controlled trial of pimobendan // Am Heart J 1992- 124 (4): 1017−24.
- Richards A. M, Nicholls M.G., Espiner E.A. et al. B-type natriuretic peptide and ejection for prognosis after miocardial infarction. Circulation 2003- 10: 2786−2792.
- Richards A.M., NcDonald D., Fitzpatrick M.A. et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988- 67: 1134−1139.
- Richards A.M., Crosier I.G. Yandle T. G et.al. Brain natriuretic factor: regional plasma concentrations and correlations with hemodynamic state in cardiac disease. Br Heart J 1993:69:414−417.
- Rimondini A, Cipolla C, Delia Bella P, et al. Flemo filtration as short-term treatment for refractory congestive heart failure. Am J Med 1987- 83:43−8.
- Ronco C, Brendolan A, Bellomo R: Continuous versus intermittent renal replacement therapy in the treatment of acute renal failure. Nefrol Dial transplant 1998- 13 (suppl 16): 79−85.
- Ronco C., Bellomo R: Critical Care Nefrology. Dordrecht, Kluwer Academic, 1998.
- Ronco C: Arterio-venous hemodiafiltration (A-V HDF): A possible way to increase urea removal during C.A.V.H. Int J Artif Organs 1985- 8: 61−62.
- Ronco C: Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993- 40: 187−198.
- Ronco C, Bellomo R: Continuous renal replacement therapy: Evolution in technology and current nomenclature. Kidney Int Suppl. 1998- 66: S 160−4.
- Ronco C, Brendolan A, Bellomo R: Online monitoring in continuous renal replacement therapies. Kidney Int Suppl 1999- 72: S8-S14.
- Ronco C, Ricci Z, Bellomo R, et. all. Extracorporeal ultrafiltration for the treatment of overhydratation congestive heart failure Cardiology 2001- 96: 155−168
- Ronco C, Ricci Z, Brenodlan A, et. all. Ultrafiltration in patient with hypervolemia and congestive heart failure. Blood Purif. 2004- 22(1): 150−163.
- Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003−24:341−356.
- Schrier RW. Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor? J Am Coll Cardiol 2006- 47: 1−8.
- Sharma A, Hermann DD, Mehta RL. Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 2001- 96: 144−154.
- Showalter C.J., Zimmerman R.S., Schwab T.R. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988- 254: R453−456.
- Silverstein ME, Ford CA, Lysaght MJ, at. all. Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974- 291: 747−751.
- Simpson IA. Ultrafiltration in the management of refractory congestive heart Br Heart J 1986- 83: 43−48
- Smith G.L., Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003−9:13−25.
- Smith S., Tan I. Ultrafiltration and haemofl ltratlon for refractiry congestive cardiac failure (letter). Lancet, 1987, v. 1, p. 1194.
- Snopek G, Kotlarska J, Daniewska D, Zelek T, Drewniak W, Krol-Jaskulska A, Dabrowski M. Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure- six case reports Kardiol Pol. 2008 Nov-66(ll): 1202−4.
- SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991- 325: 293−302.
- Stein В., Maucher H., Wiedeck H., Born B. Control of the ultrafiltration rate as the main component of a new balancing system in continuous hemofiltration. Anaesthesist, 1989- v 3 8, p 536 538.
- Stevens T.L., Burnett J.C., Kinoshita M. et al. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest 1995,95: 1101−1108.
- Stiller S., Wirtz 0., Waterbar F ., Gladziwa V., Less symptomatic hypotension using blood volume controllend ultrafiltration. ASIO Trans., 1991, v. 37. p. 139−141.
- Takeda Т., Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res 1995- 259−266.
- The RISOLVD Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evalutation of strategies for left ventricular dysfunction pilot study. Circulation 2000- 101:378−384.
- Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics—2006 update. A report from the American Heart Association Statistics Committee and the Stroke Statistics Subcommittee. Circulation 2006- 113: e85−151
- Tokano Т., Endo Т., Tanaka K., Seino Y. Effects of positive end-expiratory pressure ventillation and extracorporeal ultrafiltration method in patients with refractory heart failure. Jap. Circul. J., 1987 v.50, p. 359−367.
- Tomoda H. experimental study on the extracorporeal ultrafiltration method in congestive heart failure.- Tokai J. Exp. Clin. Med., 1986, v. 11, p. 5−11
- Troughton R., Frampton C., Yandle Т., Espiner E., Niccholls M., Richards A. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000- 355:1126−1130.
- Valli N., Gobinet A., Bordenave L. Rewiew of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 1999- 134: 437- 444.
- Walsh CT, Wagemester D. Peripheral ultrafiltration for patients with volume overload: a center’s 4-year experience. Crit Care Nurs Q. 2007 Oct-Dec- 30(4):329−36.
- Wang Т., Larson M., Levy D. et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004- 350:655−663.
- Waniewski J., Werinski A., Ahrenholz P. theoretical basis and experimental verification of the impact of ultrafiltration on dialyser clearance. Artif. Organs. 1991. v. 15 p. 70−77.
- Wei SS, Lee WT, Woo KT Slow continuous ultrafiltration (SCUF)--the safe and efficient treatment for patients with cardiac failure and fluid overload. Singapore Med J. 1995 Jun- 36(3):276−7.
- Weidmann P., Hasler L., Gnadinger M.P. et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986- 77: 734−742.136
- Wiese S., Breyer Т., Dragu A. et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricylar human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 2000- 102: 3074−3079.
- Yamamoto К., Burnett J., Jougasaki M. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension1996- 28:988−994.
- Yoshimura M., Mizino Y., Nakamuro M. et al. B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure. Am J Med 2002- 12:716−720.
- Yoshimura M., Yasue H., Okumura K. et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993- 87: 464−469.
- Zuber M., Steinmann F., Huser В., Ritz R. Incedence of arrhymais and myocardial ischemia during haemodialysis and haemofiltration. Nephr. Dial. Transplant., 1989, v.4, p.632−634.
- Миннесотский опросник качества жизни у больных с ХСН (Minnesota Living with Heart Failure Questionnaire)
- Мешала ли Вам сердечная недостаточность жить так, как хотелось бы в течение последнего месяца из-за:
- Отеков голеней, стоп 0,1,2,3,4,5
- Необходимости отдыхать днем 0,1,2,3,4,5
- Трудности подъема по лестнице 0,1,2,3,4,5
- Трудности работать по дому 0,1,2,3,4,5
- Трудности с поездками вне дома 0,1,2,3,4,5
- Нарушений ночного сна 0,1,2,3,4,5
- Трудности общения с друзьями 0,1,2,3,4,5
- Снижения заработка 0,1,2,3,4,5
- Невозможности заниматься спортом, хобби 0,1,2,3,4,5
- Сексуальных нарушений 0,1,2,3,4,5
- Ограничений в диете 0,1,2,3,4,5
- Чувства нехватки воздуха 0,1,2,3,4,5
- Необходимости лежать в больнице 0,1,2,3,4,5
- Чувства слабости, вялости 0,1,2,3,4,5
- Необходимости платить 0,1,2,3,4,5
- Побочного действия лекарств 0,1,2,3,4,5
- Чувства обузы для родных 0,1,2,3,4,5
- Чувства потери контроля 0,1,2,3,4,5
- Чувства беспокойства 0,1,2,3,4,5
- Ухудшения внимания, памяти 0,1,2,3,4,5
- Чувства депрессии 0,1,2,3,4,5
- Варианты ответов: 0 нет- 1 — очень мало-. 5 — очень много (Наивысшее качество жизни — 0 баллов- наиболее низкое — 105 баллов)